Literature DB >> 10990450

Evolutionary transition pathways for changing peptide ligand specificity and structure.

U Hoffmüller1, T Knaute, M Hahn, W Höhne, J Schneider-Mergener, A Kramer.   

Abstract

We identified evolutionary pathways for the inter- conversion of three sequentially and structurally unrelated peptides, GATPEDLNQKL, GLYEWGGARI and FDKEWNLIEQN, binding to the same site of the hypervariable region of the anti-p24 (HIV-1) monoclonal antibody CB4-1. Conversion of these peptides into each other could be achieved in nine or 10 single amino acid substitution steps without loss of antibody binding. Such pathways were identified by analyzing all 7 620 480 pathways connecting 2560 different peptides, and testing them for CB4-1 binding. The binding modes of intermediate peptides of selected optimal pathways were characterized using complete sets of substitution analogs, revealing that a number of sequential substitutions accumulated without changing the pattern of key interacting residues. At a distinct step, however, one single amino acid exchange induces a sudden change in the binding mode, indicating a flip in specificity and conformation. Our data represent a model of how different specificities, structures and functions might evolve in protein-protein recognition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990450      PMCID: PMC314224          DOI: 10.1093/emboj/19.18.4866

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

Review 1.  Antigen sequence- and library-based mapping of linear and discontinuous protein-protein-interaction sites by spot synthesis.

Authors:  U Reineke; A Kramer; J Schneider-Mergener
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

2.  Convergent solutions to binding at a protein-protein interface.

Authors:  W L DeLano; M H Ultsch; A M de Vos; J A Wells
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

3.  Spot synthesis: observations and optimizations.

Authors:  A Kramer; U Reineke; L Dong; B Hoffmann; U Hoffmüller; D Winkler; R Volkmer-Engert; J Schneider-Mergener
Journal:  J Pept Res       Date:  1999-10

4.  Structural base of the interaction of a monoclonal antibody against p24 of HIV-1 with its peptide epitope.

Authors:  W E Höhne; G Küttner; S Kiessig; G Hausdorf; R Grunow; K Winkler; H Wessner; E Giessmann; R Stigler; J Schneider-Mergener
Journal:  Mol Immunol       Date:  1993-09       Impact factor: 4.407

5.  How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.

Authors:  Y Zhou; R Abagyan
Journal:  Fold Des       Date:  1998

6.  Continuity in evolution: on the nature of transitions.

Authors:  W Fontana; P Schuster
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

7.  Detailed ab initio prediction of lysozyme-antibody complex with 1.6 A accuracy.

Authors:  M Totrov; R Abagyan
Journal:  Nat Struct Biol       Date:  1994-04

Review 8.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Authors:  K Sugamura; H Asao; M Kondo; N Tanaka; N Ishii; K Ohbo; M Nakamura; T Takeshita
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

9.  Small peptides as potent mimetics of the protein hormone erythropoietin.

Authors:  N C Wrighton; F X Farrell; R Chang; A K Kashyap; F P Barbone; L S Mulcahy; D L Johnson; R W Barrett; L K Jolliffe; W J Dower
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  4 in total

1.  On the combination of molecular replacement and single-wavelength anomalous diffraction phasing for automated structure determination.

Authors:  Santosh Panjikar; Venkataraman Parthasarathy; Victor S Lamzin; Manfred S Weiss; Paul A Tucker
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

2.  Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome.

Authors:  Shina Pashova; Lubomir Balabanski; Gabriel Elmadjian; Alexey Savov; Elena Stoyanova; Velizar Shivarov; Peter Petrov; Anastas Pashov
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

Review 3.  Carbohydrate-mimetic peptides for pan anti-tumor responses.

Authors:  Thomas Kieber-Emmons; Somdutta Saha; Anastas Pashov; Behjatolah Monzavi-Karbassi; Ramachandran Murali
Journal:  Front Immunol       Date:  2014-06-30       Impact factor: 7.561

4.  Structure-function analysis and molecular modeling of DNase catalytic antibodies.

Authors:  Haggag S Zein; Jaime A Teixeira da Silva; Kazutaka Miyatake
Journal:  Immunol Lett       Date:  2010-01-25       Impact factor: 3.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.